Selpercatinib (RETEVMO): A Breakthrough Targeted Therapy for RET-Driven Cancers What is Selpercatinib? Selpercatinib, marketed under the brand name RETEVMO, is an FDA-approved targeted therapy developed for the treatment of cancers…
Ibrutinib: Uses, Benefits, Side Effects, and More Ibrutinib is an oral medication used in the treatment of various types of blood cancers. It is a targeted therapy known as a…
Ponatinib: Uses, Benefits, Dosage, and Side Effects Ponatinib is a prescription medication used to treat certain types of leukemia. Marketed under the brand name Iclusig, Ponatinib is a tyrosine kinase…
Reviews
There are no reviews yet.